Legend Biotech Corp - Ordinary Shares (LEGN)

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Ordinary Shares
Shares outstanding
368,659,889
Total 13F shares
51,010,221
Share change
+863,525
Total reported value
$1,853,796,102
Put/Call ratio
121%
Price per share
$36.34
Number of holders
137
Value change
+$18,669,383
Number of buys
92
Number of sells
51

Institutional Holders of Legend Biotech Corp - Ordinary Shares (LEGN) as of Q1 2022

As of 31 Mar 2022, Legend Biotech Corp - Ordinary Shares (LEGN) was held by 137 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 51,010,221 shares. The largest 10 holders included HHLR ADVISORS, LTD., BlackRock Inc., Capital International Investors, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Capital World Investors, FEDERATED HERMES, INC., ALLIANCEBERNSTEIN L.P., BAKER BROS. ADVISORS LP, and Artisan Partners Limited Partnership. This page lists 137 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.